Cardio Diagnostics (NASDAQ:CDIO) Posts Quarterly Earnings Results

Cardio Diagnostics (NASDAQ:CDIO) issued its quarterly earnings data on Friday. The company reported ($0.63) earnings per share (EPS) for the quarter, Zacks reports. Cardio Diagnostics had a negative return on equity of 71.75% and a negative net margin of 40,612.50%.

Cardio Diagnostics Stock Down 7.7%

Shares of NASDAQ:CDIO opened at $1.55 on Friday. The company has a market cap of $4.59 million, a P/E ratio of -0.46 and a beta of 2.30. Cardio Diagnostics has a 52 week low of $0.97 and a 52 week high of $7.91. The company has a 50-day moving average price of $2.33 and a 200 day moving average price of $2.69.

Institutional Investors Weigh In On Cardio Diagnostics

An institutional investor recently bought a new position in Cardio Diagnostics stock. Citadel Advisors LLC acquired a new stake in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 19,520 shares of the company’s stock, valued at approximately $79,000. Citadel Advisors LLC owned 1.07% of Cardio Diagnostics as of its most recent SEC filing. 8.06% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen raised Cardio Diagnostics to a “hold” rating in a report on Saturday, March 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.